Statins associated with improvement of rare lung disease
This study suggests that oral statin therapy may be a new approach for patients with autoimmune pulmonary alveolar proteinosis.AUTHORSThe study ’s co-senior authors are Dr. Elizabeth Tarling of UCLA and Dr. Bruce Trapnell of Children’s Hospital Medical Center of Cincinnati, Ohio. Other authors are listed in the journal article.JOURNALThe study was  published in the journal Nature Communications. FUNDINGThe National Institutes of Health funded the research.Learn more about the  cardiovascular research theme at UCLA.  (Source: UCLA Newsroom: Health Sciences)
Source: UCLA Newsroom: Health Sciences - August 17, 2018 Category: Universities & Medical Training Source Type: news

Reduce high cholesterol and beat the tiredness from statins with this supplement 
HIGH cholesterol is when you have too much of a fatty substance in your blood. Statins are often prescribed to treat the condition, but if they cause you tiredness, there ’s a supplement you can take instead.  (Source: Daily Express - Health)
Source: Daily Express - Health - August 16, 2018 Category: Consumer Health News Source Type: news

Statins associated with improvement of rare lung disease
(University of California - Los Angeles Health Sciences) Researchers have found that cholesterol-lowering statins may improve the conditions of people with a rare lung disease called autoimmune pulmonary alveolar proteinosis. The research also suggested that two new tests could help diagnose the condition. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 16, 2018 Category: International Medicine & Public Health Source Type: news

Influence of Statins on Osseointegration?
Does local and systemic statin delivery affect osseointegration around implants?The postInfluence of Statins on Osseointegration? appeared first onOsseoNews Dental Implants. (Source: Dental Implants Discussed by Experts)
Source: Dental Implants Discussed by Experts - August 14, 2018 Category: Dentistry Authors: osseonews Tags: Clinical Questions Research and News Source Type: news

Healing of Apical Periodontitis after Nonsurgical Root Canal Treatment: The Role of Statin Intake
Journal of Endodontics DOI:https://doi.org/10.1016/j.joen.2018.06.013Highlights•In this longitudinal clinical study, healing of preoperative apical periodontitis was evaluated in patients on statins and control patients.•The study controlled for the following confounding variables: age, sex, length of time to evaluation, statin agent, diabetes, and cardiovascular disease.•A multivariate analysis showed a significant association between healing and the intake of statins (P 
Source: Dental Technology Blog - August 9, 2018 Category: Dentistry Source Type: news

PCP Statin Prescribing Up With Automated Patient Dashboard
TUESDAY, Aug. 7, 2018 -- Guideline-concordant statin prescribing rates are increased modestly with use of an automated dashboard using active choice framing and peer comparison, according to a study published online July 27 in JAMA Network... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 7, 2018 Category: Pharmaceuticals Source Type: news

Taking a pill can effectively treat brutal lung disease
Researchers report in Nature Communications they figured out why air sacs in the lungs clog up with a thick substance called surfactant in a brutal disease called Pulmonary Alveolar Proteinosis (PAP), and they show taking cholesterol-busting pills called statins can effectively treat the disease. That's good news for people with PAP because at present the current standard treatment is something called a whole lung lavage. (Source: World Pharma News)
Source: World Pharma News - August 7, 2018 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Taking a pill can effectively treat brutal lung disease
(Cincinnati Children's Hospital Medical Center) Researchers report in Nature Communications they figured out why air sacs in the lungs clog up with a thick substance called surfactant in a brutal disease called Pulmonary Alveolar Proteinosis (PAP), and they show taking cholesterol-busting pills called statins can effectively treat the disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 7, 2018 Category: International Medicine & Public Health Source Type: news

Atorvastatin Calcium Tablets (New - Discontinuation)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - August 2, 2018 Category: Drugs & Pharmacology Source Type: news

Do patients with LOW cholesterol need statins?
Statins can cut the risk of heart attacks even in those with low-level cholesterol, according to a major review. (Source: the Mail online | Health)
Source: the Mail online | Health - August 2, 2018 Category: Consumer Health News Source Type: news

Evolocumab + statin in CAD − cost effective in Japan?
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - August 1, 2018 Category: Drugs & Pharmacology Source Type: news

Statin Use Linked to Idiopathic Inflammatory Myositis Statin Use Linked to Idiopathic Inflammatory Myositis
In a large population-based study in an Australian population, statin exposure was associated with idiopathic inflammatory myositis.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 31, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

Can a Statin Treat Chronic Subdural Hematoma? (CME/CE)
(MedPage Today) -- Chinese trial shows atorvastatin decreased volume, improved neurologic function (Source: MedPage Today Neurology)
Source: MedPage Today Neurology - July 30, 2018 Category: Neurology Source Type: news

Inflammatory Myositis More Common With Statin Use
(MedPage Today) -- Retrospective data suggest association with rare but severe condition (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - July 30, 2018 Category: Cardiology Source Type: news

Inflammatory Myositis May Be More Common With Statin Use
(MedPage Today) -- Retrospective Australian data suggest association with rare but severe condition (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - July 30, 2018 Category: Cardiology Source Type: news

Statin'Shove' vs'Nudge'; ESC Pirates; Expanded Valsartan Recall
(MedPage Today) -- Recent developments of interest in cardiovascular medicine (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - July 30, 2018 Category: Cardiology Source Type: news

'Nudging' doctors to prescribe cholesterol-lowering statins triples prescription rates
(University of Pennsylvania School of Medicine) Pairing an online patient dashboard with 'nudges' to doctors tripled statin prescribing rates in a clinical trial led by Penn Medicine researchers. The study used two nudges, active choice framing to prompt physicians to make a decision on prescriptions, and peer comparison feedback which provided physicians with information on their performance relative to other physicians. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 27, 2018 Category: International Medicine & Public Health Source Type: news

Scientific expert reaction to Cochrane Review on omega-3 fatty acids
This study provides no evidence to suggest that this dietary advice should change.”Read the press releaseSee the media coverageDeclared interestsProf Tim Chico: “No conflicts.”Dr Ian Johnson: “Ian Johnson has previously held honorary academic appointments in the medical school at the University of East Anglia.”Prof Tom Sanders: “Scientific governor of British Nutrition Foundation, Honorary Director of Nutrition HEART UK.”The Science Media CentreThe Science Media Centre is an independent venture working to promote the voices, stories and views from the scientific community to the ne...
Source: Cochrane News and Events - July 17, 2018 Category: Information Technology Authors: Muriah Umoquit Source Type: news

Tackling Stigma
Sadly, stigma around health conditions remains a part of many patients ’ lives. Many will not disclose a diagnosis for fear of being judged by peers, employers, health professionals, colleagues and wider society. In fact, there is clear evidence that such negative societal attitudes impact health outcomes, resulting in diagnosis delays and impaired treatment.Some diseases are heavily stigmatized – including mental health, HIV/AIDS, hepatitis and some skin conditions – leading people to restrict their participation in society, impairing their chances of living happy, healthy lives.However, to one extent or...
Source: EyeForPharma - July 17, 2018 Category: Pharmaceuticals Authors: Lucy Fulford Source Type: news

The Recommended Dose podcast - JAMA Internal Medicine's Rita Redberg
This week influential Editor-in-Chief ofJAMA Internal Medicine Dr Rita Redberg joins host Ray Moynihan on Cochrane Australia's podcastThe Recommended Dose to share a wide ranging conversation on all things health. A Professor at the University of California San Francisco and high profile contributor to The Washington Post and New York Times, Rita is also a practising cardiologist who loves to see patients. She says that ‘being a doctor is really a privilege’.Together, Ray and Rita canvas many topics including shared decision making between doctors and patients, the tricky territory of medical device a...
Source: Cochrane News and Events - July 12, 2018 Category: Information Technology Authors: Muriah Umoquit Source Type: news

The Recommended Dose podcast - JAMA Internal Medicine's Rita Redberg
This week influential Editor-in-Chief ofJAMA Internal Medicine Dr Rita Redberg joins host Ray Moynihan on Cochrane Australia's podcastThe Recommended Dose to share a wide ranging conversation on all things health. A Professor at the University of California San Francisco and high profile contributor to The Washington Post and New York Times, Rita is also a practising cardiologist who loves to see patients. She says that ‘being a doctor is really a privilege’.Together, Ray and Rita canvas many topics including shared decision making between doctors and patients, the tricky territory of medical device a...
Source: Cochrane News and Events - July 12, 2018 Category: Information Technology Authors: Muriah Umoquit Source Type: news

Study Confirms Pro-Calcific Effects of Statins on Coronary Plaques in Low-Risk Patients Study Confirms Pro-Calcific Effects of Statins on Coronary Plaques in Low-Risk Patients
In patients without a history of coronary artery disease, statin use is associated with a slower progression of overall coronary atherosclerosis volume, a reduction of high-risk plaque features and accelerated plaque calcification, according to a new report from PARADIGM, a prospective multinational observational registry.Reuters Health Information (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - July 9, 2018 Category: Radiology Tags: Cardiology News Source Type: news

Post-stroke statin use linked to lower fracture risk
Patients treated with statins after a stroke show lower incidence of fractures, a study in the Journal of Clinical Metabolism reports.Healio (Source: Society for Endocrinology)
Source: Society for Endocrinology - July 6, 2018 Category: Endocrinology Source Type: news

Rhabdomyolysis and AKI Following Atorvastatin-Gemfibrozil Rhabdomyolysis and AKI Following Atorvastatin-Gemfibrozil
This case report demonstrates that severe rhabdomyolysis due to statins with or without fibrates may occur with few clinical symptoms and signs, even many weeks after discontinuation of therapy.Journal of Medical Case Reports (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 4, 2018 Category: Consumer Health News Tags: Family Medicine/Primary Care Journal Article Source Type: news

Alfred Alberts, Unsung Father of a Cholesterol Drug, Dies at 87
His discovery led to lovastatin, but he shunned the limelight — until he was a patient himself and doctors, learning who he was, treated him “ like a rock star. ” (Source: NYT Health)
Source: NYT Health - July 3, 2018 Category: Consumer Health News Authors: GINA KOLATA Tags: Alberts, Alfred W (1931-2018) Deaths (Obituaries) Statins (Cholesterol-Lowering Drugs) Merck & Company Inc Vagelos, P Roy Source Type: news

Mistrust may partly explain racial differences in statin use
(Reuters Health) - Black people in the U.S. are less likely than whites to take statins recommended to lower their cholesterol, and mistrust of the drugs and of doctors may partly explain the disparity, a recent study suggests. (Source: Reuters: Health)
Source: Reuters: Health - June 27, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Australian watchdog appeals to high court on Pfizer's alleged abuse of market power
MELBOURNE (Reuters) - Australia's competition watchdog said on Monday it would appeal to the nation's high court for a ruling on whether Pfizer Inc used its market power to limit competition for its cholesterol-lowering drug Lipitor. (Source: Reuters: Health)
Source: Reuters: Health - June 25, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

New Data Show Amgen's Repatha ® (evolocumab) Significantly Reduced LDL-C And Non-HDL-C In High-risk Patients With Type 2 Diabetes
Data Presented at the 78th Scientific Sessions of the American Diabetes Association THOUSAND OAKS, Calif., June 23, 2018 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced new data that show Repatha® (evolocumab) significantly reduced low-density lipoprotein cholesterol (LDL-C) and non-high density lipoprotein cholesterol (non-HDL-C) in patients with Type 2 diabetes and hypercholesterolemia or mixed dyslipidemia, taking the maximum tolerated dose of moderate/high-intensity statin therapy. BANTING was a dedicated study evaluating the efficacy of Repatha (monthly dosing), in lowering LDL-C and improving o...
Source: Amgen News Release - June 23, 2018 Category: Pharmaceuticals Tags: Uncategorized Source Type: news

Beliefs, Trust in Doctor Affect Statin Use Disparities by Race Beliefs, Trust in Doctor Affect Statin Use Disparities by Race
Statin-eligible African Americans were less likely than whites to see statins as effective and safe. Fewer expressed trust in their doctors'decisions. Both factors could play into their higher LDL-C levels.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 22, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

Large Lp(a) Reductions Likely Would Cut Coronary Risk, Genes Suggest
(MedPage Today) -- Mendelian'randomization'suggests potential for benefit on par with statin (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - June 21, 2018 Category: Primary Care Source Type: news

More than 450 deaths ‘without medical justification’ Gosport enquiry finds
Shortening of lives ‘institutionalised’ at Gosport War Memorial Hospital in 1989-2000 Related items fromOnMedica Hunt announces Medicines and Medical Devices Safety Review CQC finds safety concerns with online primary care Treatment of whistleblowers a “stain on NHS”, say MPs GPs defend practice on prescribing statins Multidisciplinary prescribing can help reduce errors (Source: OnMedica Latest News)
Source: OnMedica Latest News - June 20, 2018 Category: UK Health Source Type: news

African-Americans Less Likely to Get Recommended Statin Therapy
THURSDAY, June 14, 2018 -- African-Americans are less likely than whites to be treated with statins or to receive a statin at guideline-recommended intensity, according to a study published online June 13 in JAMA Cardiology. Michael G. Nanna, M.D.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 14, 2018 Category: Pharmaceuticals Source Type: news

Why Are Statins Underused With Black Patients?
Title: Why Are Statins Underused With Black Patients?Category: Health NewsCreated: 6/13/2018 12:00:00 AMLast Editorial Review: 6/14/2018 12:00:00 AM (Source: MedicineNet Cholesterol General)
Source: MedicineNet Cholesterol General - June 14, 2018 Category: Cardiology Source Type: news

Blacks Still Show Lower Statin Treatment Rates than Whites
(MedPage Today) -- Guideline-recommended therapy more often skipped in African Americans (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - June 13, 2018 Category: American Health Source Type: news

Why Are Statins Underused With Black Patients?
WEDNESDAY, June 13, 2018 -- The color of a patient's skin appears to influence the medical care they receive for high cholesterol levels, a new study shows. Blacks are less likely than whites to receive appropriate treatment with... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 13, 2018 Category: General Medicine Source Type: news

Statins - - Doing More Than Lowering Your Cholesterol?
Title: Statins - - Doing More Than Lowering Your Cholesterol?Category: Doctor's& Expert's views on SymptomsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 6/13/2018 2:55:09 PM (Source: MedicineNet Cholesterol General)
Source: MedicineNet Cholesterol General - June 13, 2018 Category: Cardiology Source Type: news

UA receives $1.1 million for study of genetic risk factors for type 2 diabetes and heart disease
(University of Arizona Health Sciences) Some people who take statins to lower cholesterol have a slightly higher risk of developing type 2 diabetes. Genetic epidemiologist Yann Klimentidis, Ph.D., at the UA Mel and Enid Zuckerman College of Public Health received a $1.1 million grant from the National Institutes of Health to study the connection between type 2 diabetes and cardiovascular disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 11, 2018 Category: International Medicine & Public Health Source Type: news

New Equation May Better Estimate Cardiovascular Disease Risk New Equation May Better Estimate Cardiovascular Disease Risk
If further validated, this new risk calculator would have major implications for selecting patients eligible for statins, aspirin, and antihypertensive therapy.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 6, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Medical News Today: 'Millions' prescribed wrong dose of common drugs
By updating old cardiovascular risk analyses, researchers alter the guidelines for prescribing statins, aspirin, and blood pressure drugs. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 5, 2018 Category: Consumer Health News Tags: Public Health Source Type: news

Statin recommendations may change, especially for African-Americans
Dr. Sanjay Basu was treating an African-American man whom he intuitively thought would be at a high risk for a stroke. The patient smoked; he was older and had high cholesterol. But when the doctor of internal medicine and assistant professor of medicine at Stanford University put these details into an application that calculates a person's risk based on current guidelines, it didn't agree with him. (Source: CNN.com - Health)
Source: CNN.com - Health - June 4, 2018 Category: Consumer Health News Source Type: news

More than 10 million Americans are likely taking the wrong drugs for heart health
More than 50 mil;lion Americans are recommended to take aspirin, statin or blood pressure medication, but new Stanford University research suggests those numbers are incorrect. (Source: the Mail online | Health)
Source: the Mail online | Health - June 4, 2018 Category: Consumer Health News Source Type: news

Heart Meds May Be Wrong for Millions of Americans
MONDAY, June 4, 2018 -- Millions of Americans may be getting the wrong treatment to prevent a heart attack or stroke, a new study suggests. Prescriptions for blood-thinning aspirin, cholesterol-lowering statins and blood pressure medications might... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 4, 2018 Category: General Medicine Source Type: news

Ask Well: How Many People Can ’ t Tolerate Statins?
Medical researchers, normally a genteel lot, disagree sharply on the extent to which side effects from statin drugs are a problem. (Source: NYT Health)
Source: NYT Health - June 1, 2018 Category: Consumer Health News Authors: RICHARD KLASCO, M.D. Tags: Cholesterol Muscles Statins (Cholesterol-Lowering Drugs) Placebos Heart Drugs (Pharmaceuticals) Source Type: news

Lipids and Lipid Lowering With Statins and PCSK9 Inhibitors Lipids and Lipid Lowering With Statins and PCSK9 Inhibitors
This commentary summarizes multiple recent studies on the use of statins and PCSK9 inhibitors as well as new insights into the relationship of HDL, LDL, the immune system, and atherosclerosis.European Heart Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 31, 2018 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Association of statin use with increased risk of musculoskeletal conditions: a retrospective cohort study - Makris UE, Alvarez CA, Mortensen EM, Mansi IA.
INTRODUCTION: Musculoskeletal conditions, including osteoarthritis (OA), result in tremendous disability and cost. Statins are among the most commonly prescribed medications and their use for primary prevention in many otherwise healthy individuals, includ... (Source: SafetyLit)
Source: SafetyLit - May 30, 2018 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Australian anti-trust watchdog loses appeal against Pfizer over Lipitor sales
MELBOURNE (Reuters) - An Australian court dismissed an appeal by the nation's anti-trust watchdog in a case against Pfizer Inc in which the regulator alleged the company had used its market power to limit competition for its cholesterol-lowering drug Lipitor. (Source: Reuters: Health)
Source: Reuters: Health - May 25, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

UNDER THE MICROSCOPE: Chris Tarrant answers our health quiz  
The TV star, from Reading, walks three miles a day, watches what he eats and still enjoys sex. He's also taken statins and a blood-thinner since suffering a stroke in 2014. (Source: the Mail online | Health)
Source: the Mail online | Health - May 21, 2018 Category: Consumer Health News Source Type: news

Statins in Peripheral Artery Disease: Why Are We Waiting? Statins in Peripheral Artery Disease: Why Are We Waiting?
Should high-intensity statin therapy be prescribed for patients with atherosclerotic peripheral artery disease?Circulation (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 21, 2018 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

AstraZeneca sales hit by generic competitors to Crestor statin
Pharma group’s core operating profit falls 47% in first quarter (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - May 18, 2018 Category: Pharmaceuticals Source Type: news

Metformin Reduces Mild Statin-Induced Myalgia
Risk of non-severe statin muscle pain reduced in T2DM patients taking both metformin and statins, according to this recent study.   (Source: ConsultantLive)
Source: ConsultantLive - May 15, 2018 Category: Internal Medicine Authors: Gregory M. Weiss, MD Source Type: news